Prostatic Neoplasms

"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the PROSTATE.

Descriptor ID	D011471
MeSH Number(s)	C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
Concept/Terms	Prostatic Neoplasms Prostatic Neoplasms Prostate Neoplasms Neoplasms, Prostate Neoplasm, Prostate Prostate Neoplasm Neoplasms, Prostatic Neoplasm, Prostatic Prostatic Neoplasm Prostate Cancer Prostate Cancer Cancer, Prostate Cancers, Prostate Prostate Cancers Cancer of the Prostate Prostatic Cancer Cancer, Prostatic Cancers, Prostatic Prostatic Cancers Cancer of Prostate

Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Genital Neoplasms, Male [C04.588.945.440]
Prostatic Neoplasms [C04.588.945.440.770]
Male Urogenital Diseases [C12]
Genital Diseases, Male [C12.294]
Genital Neoplasms, Male [C12.294.260]
Prostatic Neoplasms [C12.294.260.750]
Prostatic Diseases [C12.294.565]
Prostatic Neoplasms [C12.294.565.625]
Urogenital Neoplasms [C12.758]
Genital Neoplasms, Male [C12.758.409]
Prostatic Neoplasms [C12.758.409.750]

Below are MeSH descriptors whose meaning is related to "Prostatic Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".

Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 794 publications over 30 distinct years, with a maximum of 52 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	3	0	3
1999	1	0	1
2000	5	1	6
2001	10	0	10
2002	4	1	5
2003	10	2	12
2004	15	2	17
2005	16	1	17
2006	24	4	28
2007	21	6	27
2008	28	3	31
2009	26	2	28
2010	38	8	46
2011	35	7	42
2012	48	4	52
2013	39	3	42
2014	35	5	40
2015	42	4	46
2016	42	1	43
2017	36	3	39
2018	25	6	31
2019	29	1	30
2020	38	1	39
2021	29	0	29
2022	33	0	33
2023	38	0	38
2024	30	1	31
2025	22	0	22
2026	5	0	5

Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.

Adeyika TA, Datturgi A, Ettinoffe Y, Ghosh S, Albanese C, Kwabi-Addo B. Epigenetic dysregulation and biological function of PDX1 in prostate cancer. Oncotarget. 2026 Mar 31; 17(1):157-172.

View in: PubMed
Byrd CJ, Evans M, Kim W, Knight Q, Liou GY. Cytokines IL-6, IL-10, and CCL5 Secreted by Infiltrating B Cells Promote Cell Migration of Human Prostate Cancer Cell Lines. Oncol Res. 2026; 34(4):15.

View in: PubMed
Ofori-Minta K, Wang B, Mohl JE, Mandal A, Leung MY. Clinicogenomic Insights for Progression-Free Survival in Prostate Cancer. Int J Environ Res Public Health. 2026 Feb 18; 23(2).

View in: PubMed
Read GH, Pacheco JV, Baumann B, Richards ZA, Deaton R, Macias V, Kajdacsy-Balla A, Kittles R, Abern MR, Nonn L. Dysregulation of estrogen signaling and HSD17B7 in the prostate stroma of African American men. Endocrinology. 2026 Feb 04; 167(3).

View in: PubMed
Al-Mathkour MM, Dwead AM, Khazaw K, Cinar B. The YAP1 and EPHA3 receptor tyrosine kinase axis regulates cellular plasticity and treatment response. Cell Signal. 2026 May; 141:112368.

View in: PubMed
Hwang BJ, Akinniyi O, Harrison S, Gibbs D, Waihenya C, Gachii A, Dike PE, Elliott B, Khalifa F, Ragin C, Odero-Marah V. AI/ML-Assisted Detection of HMGA2 RNA Isoforms in Prostate Cancer Patient Tissue. Int J Mol Sci. 2025 Dec 24; 27(1).

View in: PubMed
Perri A, Tylecki A, Vigan? S, Bertini A, Finocchiaro A, Santangelo A, Silvani C, Hussain B, Lughezzani G, Buffi N, Rossanese M, Ficarra V, Sood A, Gandaglia G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized Prostate Cancer in a North American Statewide Cohort. Urol Pract. 2026 Mar; 13(2):98-110.

View in: PubMed
Korn SM, Dagnino F, Daniels D, Qian Z, Zurl H, Pohl KK, Hsieh MC, Hernandez BY, Piccolini A, Cole AP, Reich AJ, Weissman JS, Trinh QD, Iyer HS. Travel Time to Treating Facility and Mortality in Men With Prostate Cancer. JAMA Netw Open. 2025 Dec 01; 8(12):e2546812.

View in: PubMed
Qiu C, Wang X, Francia G, Casiano CA, Zhang JY. A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection. Br J Cancer. 2026 Feb; 134(3):493-503.

View in: PubMed
Mssika A, Robinson B, Tinsley S, Bertini A, Stephens A, Finocchiaro A, Vigano S, Perri A, Lughezzani G, Buffi N, Sorce G, Ficarra V, Salonia A, Briganti A, Montorsi F, Sood A, Rogers C, Abdollah F. Disparities in Prostate Cancer-Specific Mortality in Incarcerated vs Nonincarcerated Patients in Michigan: A Statewide Retrospective Cohort Study. Urol Pract. 2026 Jan; 13(1):24-32.

View in: PubMed

People

Explore

Similar Concepts

Top Journals